Jan W. Eriksson
University of Helsinki(FI)Singapore Institute for Clinical Sciences(SG)Folkhälsans Forskningscentrum(FI)
Publications by Year
Research Areas
Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism, Pancreatic function and diabetes, Diet and metabolism studies
Most-Cited Works
- → Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes(2002)423 cited
- → Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study(2018)379 cited
- → Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis(2017)365 cited
- → Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial(2019)329 cited
- → Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity(2019)320 cited
- → Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS)